KOSDAQ · Healthcare · ₩265B
₩3,6700.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 0.0% · as of 26.09.11
Among 34 바이오 peers
Quarterly Revenue Growth
“이번 분기는 기존 진단 사업이 버티며 세포치료제의 다음 단계를 준비해요.”
In the company's words · 2026 2분기 filing